{"id":401512,"date":"2020-12-17T01:33:15","date_gmt":"2020-12-17T06:33:15","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=401512"},"modified":"2020-12-17T01:33:15","modified_gmt":"2020-12-17T06:33:15","slug":"evaxion-biotech-appoints-marianne-sogaard-as-chairwoman","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/","title":{"rendered":"Evaxion Biotech Appoints Marianne S\u00f8gaard as Chairwoman"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">COPENHAGEN, Denmark, Dec.  17, 2020  (GLOBE NEWSWIRE) &#8212; Evaxion Biotech A\/S, a clinical-stage biotechnology company developing AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced today the appointment of previously practicing commercial, technology and corporate lawyer Marianne S\u00f8gaard as Chairwoman of the Board of Directors.<\/p>\n<p>Marianne S\u00f8gaard has been an executive and most recently Senior Vice President and General Counsel at Evaxion since 2018. Prior to that, she served for 22 years as lawyer and partner of the law firm Poul Schmith where she primarily focused on acquisitions of processes and technology solutions. She was also a member of the Board of Directors of Poul Schmith from 2014 to 2017. Currently, Mrs. S\u00f8gaard serves on a number of Boards of technology companies, including How to Robot and Altapay.<\/p>\n<p align=\"justify\">Lars Wegner, CEO of Evaxion, said: \u201cWe are very pleased to welcome Marianne S\u00f8gaard as the new Chairwoman of Evaxion. Marianne has been part of our team since 2018 and has been invaluable in the development and execution of our business model. With her extensive experience in legal affairs and technology, Marianne will provide important guidance and advice as we continue to develop our AI platforms to advance our product candidates through clinical development.\u201d<\/p>\n<p align=\"justify\">Marianne S\u00f8gaard, Chairwoman of Evaxion, said: \u201cIt is an honor to become Chairwoman of Evaxion at such an exciting point in the company\u2019s development. Evaxion is built on technology that we believe has the potential to revolutionize how cancer and infectious diseases are treated. I look forward to working together with the team and to playing my part in this journey.\u201d<\/p>\n<p align=\"justify\">\n        <strong>About Evaxion Biotech<\/strong>\n      <\/p>\n<p align=\"justify\">Evaxion Biotech A\/S is a clinical stage AI-immunology\u2122\u00a0platform company decoding the human immune system to discover and develop novel immunotherapies to treat cancer and infectious diseases. Based on its proprietary and scalable AI-immunology core technology, Evaxion Biotech is developing a broad pipeline of novel product candidates which currently includes three patient-specific cancer immunotherapies, two of which are in Phase 1\/2 clinical development. In addition, the Company is advancing a portfolio of vaccines to treat bacterial and viral infections with one program currently in preclinical development against S. aureus (including Methicillin-resistant S. aureus, or MRSA) induced skin and soft tissue infections (SSTI).<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td colspan=\"2\">\n            <strong>For more information<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:22%;width:22%;min-width:22%\">Evaxion <br \/>Glenn S. Vraniak <br \/>Chief Financial Officer <br \/>gvr@evaxion-biotech.com <br \/>+1 (513) 476-2669<\/td>\n<td style=\"max-width:78%;width:78%;min-width:78%\">LifeSci Advisors LLC<br \/>Mary-Ann Chang<br \/>Managing Director<br \/>mchang@lifesciadvisors.com<br \/>+44 7483 284 853<\/td>\n<\/tr>\n<\/table>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzQ1OCMzODg0ODY5IzUwMDA2OTA4NQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/d4652e4e-c0e4-485d-8056-8a7655529efb\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>COPENHAGEN, Denmark, Dec. 17, 2020 (GLOBE NEWSWIRE) &#8212; Evaxion Biotech A\/S, a clinical-stage biotechnology company developing AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced today the appointment of previously practicing commercial, technology and corporate lawyer Marianne S\u00f8gaard as Chairwoman of the Board of Directors. Marianne S\u00f8gaard has been an executive and most recently Senior Vice President and General Counsel at Evaxion since 2018. Prior to that, she served for 22 years as lawyer and partner of the law firm Poul Schmith where she primarily focused on acquisitions of processes and technology solutions. She was also a member of the Board of Directors of Poul Schmith from 2014 to 2017. Currently, Mrs. S\u00f8gaard serves on &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Evaxion Biotech Appoints Marianne S\u00f8gaard as Chairwoman&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-401512","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Evaxion Biotech Appoints Marianne S\u00f8gaard as Chairwoman - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evaxion Biotech Appoints Marianne S\u00f8gaard as Chairwoman - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"COPENHAGEN, Denmark, Dec. 17, 2020 (GLOBE NEWSWIRE) &#8212; Evaxion Biotech A\/S, a clinical-stage biotechnology company developing AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced today the appointment of previously practicing commercial, technology and corporate lawyer Marianne S\u00f8gaard as Chairwoman of the Board of Directors. Marianne S\u00f8gaard has been an executive and most recently Senior Vice President and General Counsel at Evaxion since 2018. Prior to that, she served for 22 years as lawyer and partner of the law firm Poul Schmith where she primarily focused on acquisitions of processes and technology solutions. She was also a member of the Board of Directors of Poul Schmith from 2014 to 2017. Currently, Mrs. S\u00f8gaard serves on &hellip; Continue reading &quot;Evaxion Biotech Appoints Marianne S\u00f8gaard as Chairwoman&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-17T06:33:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzQ1OCMzODg0ODY5IzUwMDA2OTA4NQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Evaxion Biotech Appoints Marianne S\u00f8gaard as Chairwoman\",\"datePublished\":\"2020-12-17T06:33:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\\\/\"},\"wordCount\":402,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzQ1OCMzODg0ODY5IzUwMDA2OTA4NQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\\\/\",\"name\":\"Evaxion Biotech Appoints Marianne S\u00f8gaard as Chairwoman - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzQ1OCMzODg0ODY5IzUwMDA2OTA4NQ==\",\"datePublished\":\"2020-12-17T06:33:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzQ1OCMzODg0ODY5IzUwMDA2OTA4NQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzQ1OCMzODg0ODY5IzUwMDA2OTA4NQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evaxion Biotech Appoints Marianne S\u00f8gaard as Chairwoman\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evaxion Biotech Appoints Marianne S\u00f8gaard as Chairwoman - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/","og_locale":"en_US","og_type":"article","og_title":"Evaxion Biotech Appoints Marianne S\u00f8gaard as Chairwoman - Market Newsdesk","og_description":"COPENHAGEN, Denmark, Dec. 17, 2020 (GLOBE NEWSWIRE) &#8212; Evaxion Biotech A\/S, a clinical-stage biotechnology company developing AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced today the appointment of previously practicing commercial, technology and corporate lawyer Marianne S\u00f8gaard as Chairwoman of the Board of Directors. Marianne S\u00f8gaard has been an executive and most recently Senior Vice President and General Counsel at Evaxion since 2018. Prior to that, she served for 22 years as lawyer and partner of the law firm Poul Schmith where she primarily focused on acquisitions of processes and technology solutions. She was also a member of the Board of Directors of Poul Schmith from 2014 to 2017. Currently, Mrs. S\u00f8gaard serves on &hellip; Continue reading \"Evaxion Biotech Appoints Marianne S\u00f8gaard as Chairwoman\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-17T06:33:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzQ1OCMzODg0ODY5IzUwMDA2OTA4NQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Evaxion Biotech Appoints Marianne S\u00f8gaard as Chairwoman","datePublished":"2020-12-17T06:33:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/"},"wordCount":402,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzQ1OCMzODg0ODY5IzUwMDA2OTA4NQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/","name":"Evaxion Biotech Appoints Marianne S\u00f8gaard as Chairwoman - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzQ1OCMzODg0ODY5IzUwMDA2OTA4NQ==","datePublished":"2020-12-17T06:33:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzQ1OCMzODg0ODY5IzUwMDA2OTA4NQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzQ1OCMzODg0ODY5IzUwMDA2OTA4NQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-biotech-appoints-marianne-sogaard-as-chairwoman\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Evaxion Biotech Appoints Marianne S\u00f8gaard as Chairwoman"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=401512"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401512\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=401512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=401512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=401512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}